LINDAHL RICHARD S (EVP, Chief Financial Officer) reported 2 transactions at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/10/2026ACC: 0001196632-26-000003
Officer· EVP, Chief Financial Officer
Since May 2025
-51.80K
Net shares
Net seller
$565.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
51.80K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−46.16K
Price / share
$10.92
Trade value
$504.01K
% of position
15.8%
2/6/2026
291.50K→245.34K
Common Stock
Direct
Shares
−5.64K
Price / share
$10.92
Trade value
$61.61K
% of position
2.3%
2/6/2026
245.34K→239.70K
Total
Net shares
−51.80K
Net value
-$565.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/6/2026 | D · Disposition | −46.16K | $10.92 | $504.01K | 15.8% | 291.50K | 245.34K |
| Common Stock Direct | 2/6/2026 | F · Tax Withholding | −5.64K | $10.92 | $61.61K | 2.3% | 245.34K | 239.70K |
| Total | −51.80K | -$565.62K | ||||||
Derivative Transactions0
No derivative transactions reported